Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus
- PMID: 19910143
- DOI: 10.1016/j.ijrobp.2009.07.1681
Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus
Abstract
Purpose: To determine the optimal method of using (18)F-fluorothymidine (FLT) positron emission tomography (PET)/computed tomography (CT) simulation to delineate the gross tumor volume (GTV) in esophageal squamous cell carcinoma verified by pathologic examination and compare the results with those using (18)F-fluorodeoxyglucose (FDG) PET/CT.
Methods and materials: A total of 22 patients were enrolled and underwent both FLT and FDG PET/CT. The GTVs with biologic information were delineated using seven different methods in FLT PET/CT and three different methods in FDG PET/CT. The results were compared with the pathologic gross tumor length, and the optimal threshold was obtained. Next, we compared the simulation plans using the optimal threshold of FLT and FDG PET/CT. The radiation dose was prescribed as 60 Gy in 30 fractions with a precise radiotherapy technique.
Results: The mean +/- standard deviation pathologic gross tumor length was 4.94 +/- 2.21 cm. On FLT PET/CT, the length of the standardized uptake value 1.4 was 4.91 +/- 2.43 cm. On FDG PET/CT, the length of the standardized uptake value 2.5 was 5.10 +/- 2.18 cm, both of which seemed more approximate to the pathologic gross tumor length. The differences in the bilateral lung volume receiving > or =20 Gy, heart volume receiving > or =40 Gy, and the maximal dose received by spinal cord between FLT and FDG were not significant. However, the values for mean lung dose, bilateral lung volume receiving > or =5, > or =10, > or =30, > or =40, and > or =50 Gy, mean heart dose, and heart volume receiving > or =30 Gy using FLT PET/CT-based planning were significant lower than those using FDG PET/CT.
Conclusion: A standardized uptake value cutoff of 1.4 on FLT PET/CT and one of 2.5 on FDG PET/CT provided the closest estimation of GTV length. Finally, FLT PET/CT-based treatment planning provided potential benefits to the lungs and heart.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Gradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning.Radiat Oncol. 2015 Jan 9;10:11. doi: 10.1186/s13014-014-0304-5. Radiat Oncol. 2015. PMID: 25572431 Free PMC article.
-
Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.J Nucl Med. 2010 Apr;51(4):528-34. doi: 10.2967/jnumed.109.072124. Epub 2010 Mar 17. J Nucl Med. 2010. PMID: 20237030 Clinical Trial.
-
Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.Dis Esophagus. 2012 Jul;25(5):416-26. doi: 10.1111/j.1442-2050.2011.01259.x. Epub 2011 Sep 23. Dis Esophagus. 2012. PMID: 21951837 Clinical Trial.
-
Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.Abdom Radiol (NY). 2017 Mar;42(3):951-961. doi: 10.1007/s00261-016-0947-9. Abdom Radiol (NY). 2017. PMID: 27770160 Review.
-
Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.World J Gastroenterol. 2011 Dec 14;17(46):5059-74. doi: 10.3748/wjg.v17.i46.5059. World J Gastroenterol. 2011. PMID: 22171140 Free PMC article. Review.
Cited by
-
[F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?Strahlenther Onkol. 2021 Sep;197(9):780-790. doi: 10.1007/s00066-020-01701-0. Epub 2020 Oct 26. Strahlenther Onkol. 2021. PMID: 33104815 Free PMC article.
-
Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview.Ann Transl Med. 2016 Feb;4(3):53. doi: 10.3978/j.issn.2305-5839.2016.01.26. Ann Transl Med. 2016. PMID: 26904575 Free PMC article. Review.
-
What Is the Appropriate Clinical Target Volume for Esophageal Squamous Cell Carcinoma? Debate and Consensus Based on Pathological and Clinical Outcomes.J Cancer. 2016 Jan 1;7(2):200-6. doi: 10.7150/jca.13873. eCollection 2016. J Cancer. 2016. PMID: 26819644 Free PMC article. Review.
-
Effectiveness of PET/CT with (18)F-fluorothymidine in the staging of patients with squamous cell head and neck carcinomas before radiotherapy.Rep Pract Oncol Radiother. 2015 May-Jun;20(3):210-6. doi: 10.1016/j.rpor.2015.01.005. Epub 2015 Feb 17. Rep Pract Oncol Radiother. 2015. PMID: 25949225 Free PMC article.
-
Comparison of different images in gross target volume delineating on VX2 nasopharyngeal transplantation tumor models.J Cancer. 2020 Jan 1;11(5):1104-1114. doi: 10.7150/jca.36076. eCollection 2020. J Cancer. 2020. PMID: 31956357 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical